Helen Torley

CIK 1528185 · PRESIDENT AND CEO · last filed 2026-06-03

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.27M

Companies

4

Total Filings

116

Lifetime Open-Market Net

-$87.67M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
HTI PRESIDENT AND CEO 767,780 -$83.25M 89 2026-06-03
DGX Director 6,260 $203.06 $1.27M $0 7 2021-05-25
Relypsa Inc (RLYP) Delisted Director 0 -$19.6K 5 2016-09-02
ONYX PHARMACEUTICALS INC (ONXX) Delisted EVP, Chief Commercial Officer 35,911 -$4.40M 14 2013-09-05

Recent Filings · Page 3 of 12

116 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-02-14 HTI Grant (A) $0 EDGAR
2024-12-03 HTI Gift (G) −10,000 $0 EDGAR
2024-10-09 HTI Mixed -$788.3K EDGAR
2024-09-26 HTI Mixed -$1.29M EDGAR
2024-09-12 HTI Mixed -$1.36M EDGAR
2024-08-15 HTI Mixed -$1.30M EDGAR
2024-02-27 HTI Grant (A) $0 EDGAR
2024-02-20 HTI Mixed +17,522 -$735.1K EDGAR
2024-02-16 HTI Mixed +21,218 -$885.4K EDGAR
2024-02-13 HTI Mixed +14,338 -$601.3K EDGAR
Showing 2130 of 116
Page 3 of 12
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.